ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,526Medicare Part D Prescriptions Filled, Including Refills

Rank: 1323 out of 3647

$861K Total Retail Price of All Prescriptions

Rank: 334 out of 3647

256 Patients Receiving at Least One Drug in Part D
51%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 256 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

27% of this provider’s 256 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 3,950 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$114 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
FUROSEMIDE 334 225 1 8
LISINOPRIL 199 136 2 4
OMEPRAZOLE 189 106 3 3
AMLODIPINE BESYLATE 156 90 4 2
ZOLPIDEM TARTRATE 130 28 5 14
HYDROCODONE-ACETAMINOPHEN 126 56 S3 6 12
LYRICA 124 53 7 120
SPIRONOLACTONE 122 52 8 77
METFORMIN HCL 117 78 9 6
HYDROCHLOROTHIAZIDE 116 64 10 9
ACYCLOVIR 114 16 11 259
SIMVASTATIN 114 68 11 1
POTASSIUM CHLORIDE 113 58 13 24
MELOXICAM 111 87 14 33
LEVOTHYROXINE SODIUM 110 89 15 5
PREDNISONE 106 64 16 43
LANTUS 99 47 17 59
GLIMEPIRIDE 96 57 18 45
SULFAMETHOXAZOLE-TRIMETHOPRIM 95 45 19 110
HYDROCODONE BIT-IBUPROFEN 92 41 S3 20 417
TRUVADA 89 0 21 158
DONEPEZIL HCL 88 70 22 30
METOPROLOL TARTRATE 87 67 23 7
PANTOPRAZOLE SODIUM 81 54 24 38
ESCITALOPRAM OXALATE 78 63 25 65
CLOPIDOGREL 76 52 26 26
CARVEDILOL 76 50 26 20
CLONIDINE HCL 68 27 28 46
FLUCONAZOLE 68 18 28 226
AZITHROMYCIN 66 23 30 34
TRAZODONE HCL 63 13 31 64
DAPSONE 62 11 32 505
ATENOLOL 60 46 33 10
WARFARIN SODIUM 57 46 34 15
NORVIR 56 0 35 154
CIPROFLOXACIN HCL 56 36 35 53
SINGULAIR 52 33 37 90
PLAVIX 52 42 37 39
CARISOPRODOL 50 0 R 39 115
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 3, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.